Skip to main content
TipRanks
Go Ultimate75% OFF

Curative Biotechnology (CUBT) Income Statement

20 Followers

Curative Biotechnology Income Statement

Last quarter (Q2 2026), Curative Biotechnology's total revenue was $0.00. In Q2, Curative Biotechnology's net income was $-608.91K. See Curative Biotechnology’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Dec 21
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
$ -87.84K$ -92.21K$ -97.52K$ -7.96K$ -6.74K
$ 1.41M$ 2.35M$ 1.83M$ 4.44M$ 5.00M
Depreciation and Amortization$ 87.84K$ 92.21K$ 97.52K$ 99.80K$ 6.74K
$ -1.41M$ -2.35M$ -2.50M$ -4.36M$ -5.16M
$ -1.50M$ -2.44M$ -1.93M$ -4.47M$ -5.01M
$ -761.01K$ -1.12M$ -2.02M$ -913.57K$ -326.00K
$ -2.26M$ -3.56M$ -3.96M$ -5.38M$ -5.34M
$ -2.26M$ -3.56M$ -3.96M$ -5.38M$ -5.34M
Per Share Metrics
Basic EPS$ -0.00$ -0.60$ -1.32$ -1.47$ -5.64
Diluted EPS$ -0.00$ -0.60$ -1.32$ -1.44$ -5.64
Weighted Average Shares Outstanding1.02B6.05M4.41M3.75M2.15M
Weighted Average Shares Outstanding (Diluted)1.02B6.05M4.41M3.81M2.15M

Currency in USD

Curative Biotechnology Earnings and Revenue History

-6M-3M03M0 %0.4 %0.8 %1.2 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin